Publications
& Policy

Europe stands at a crossroads for biotech and healthcare, as it continues to lose companies, capital, talent and clinical activity to more competitive ecosystems abroad. The European Biotech Act I’s delivery must be comprehensive and future-proof.  Invest Europe’s position sets out how the Act can become a true end‑to‑end ecosystem strategy. Without addressing remaining structural bottlenecks, Europe risks continued underperformance in a sector that is central to competitiveness, health security and strategic autonomy.

AI is at the centre of today’s conversations in private equity—but where does it truly add value?

In this response we highlight to European Insurance and Occupational Pensions Authority (EIOPA) our concerns that focusing draft supervisory statement specifically on private equity ownership models would create a de facto two-tiered regime which, in effect, would apply a higher, more onerous standard to a private equity acquirer.

In this response, EU policymakers should use the forthcoming revision of the banking framework, as suggested by the European Council, to introduce targeted and proportionate changes to the credit risk treatment of diversified long-term equity exposures under Article 133 of the Capital Requirements Regulation.

Weak IPO markets, fragmented capital markets, regulatory complexity and limited institutional capital continue to constrain exits across the investment lifecycle. While a private intermittent trading platform could play a complementary role in selected cases, Invest Europe's response stresses that any such solution must remain proportionate, issuer‑controlled and market‑led - and must not undermine the fund‑based model that underpins private investment in Europe.

The GBER plays a central role in shaping how State aid mobilises private capital to support innovation, growth and competitiveness in Europe. While the Commission’s draft for the 2027-2034 period introduces welcome flexibility, Invest Europe’s position highlights remaining structural misalignments that risk excluding viable, PE/VC‑backed companies from support.

This paper sets out Invest Europe’s views on the European Commission’s Omnibus initiative to simplify EU direct taxation, highlighting the challenges posed by complexity, fragmentation, and inconsistent implementation across Member States. It provides targeted policy recommendations to streamline tax rules, reduce administrative burdens, and support efficient cross-border investment, competitiveness, and sustainable economic growth in Europe.

The Invest Europe ESG KPI Report is the first annual ESG and sustainability data survey to track the industry’s efforts in tackling issues such as climate change, female under-representation and bribery and corruption. Through this initiative – alongside the creation of Invest Europe’s ESG Reporting Guidelines – European private equity can become an undisputed leader and standard setter on ESG measurement and reporting across the global private capital industry.

The Market Integration package takes meaningful steps toward removing long-standing barriers that have hindered fund managers’ ability to operate cross-border, while reflecting on the diversity of EU market. Nearly all of the proposed amendments on asset management will help usually small private equity, venture capital and infrastructure managers to operate more efficiently across the Union – and will therefore unlock capital for the companies they support.

In the context of start-up and scale-up strategy, fragmented EU tax rules complicate equity-based compensation, limiting talent mobility and cross-border growth. This position paper outlines harmonised solutions, including deferred taxation, common equity instruments, and the 28th regime (“EU Inc”), to support scalable, pan-European growth and long-term value creation.